ACKR1 | Atypical chemokine receptor 1 (Duffy blood group) | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16421/154116_A_9_11_selected_60x60.jpg) | ![](/images/17672/41563_B_8_2_rna_selected_60x60.jpg) | Mixed |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13819/30339_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
ACKR3 | Atypical chemokine receptor 3 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| ![](/images/49718/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49718/116962_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
ACKR4 | Atypical chemokine receptor 4 | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/49877/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49877/113059_B_9_1_rna_selected_60x60.jpg) | Group enriched |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images/52157/823_C8_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/28509/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28509/61500_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/29679/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29678/70371_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/38789/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38789/80138_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADRA2A | Adrenoceptor alpha 2A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
ADRA2B | Adrenoceptor alpha 2B | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/66029/154301_B_9_8_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66029/154298_B_1_4_rna_selected_60x60.jpg) | Mixed |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/57688/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/57688/ihc_cell_selected_60x60.jpg) | ![](/images/57688/133031_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/67972/150140_A_4_8_selected_60x60.jpg) | ![](/images/67972/149849_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
ADRB2 | Adrenoceptor beta 2, surface | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/3431/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3431/11305_B_9_4_rna_selected_60x60.jpg) | Mixed |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/3596/ihc_cell_selected_60x60.jpg) | ![](/images/3596/11016_B_9_3_rna_selected_60x60.jpg) | Group enriched |
AGTR2 | Angiotensin II receptor, type 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
APLF | Aprataxin and PNKP like factor | Enzymes G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/34642/68665_B_6_1_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/34642/68664_B_8_1_rna_selected_60x60.jpg) | Mixed |
APLNR | Apelin receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/25842/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25842/57364_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
AVPR1A | Arginine vasopressin receptor 1A | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AVPR1B | Arginine vasopressin receptor 1B | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/17337/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17337/111003_B_7_8_rna_selected_60x60.jpg) | Not detected |
AVPR2 | Arginine vasopressin receptor 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/46678/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46678/108998_A_3_1_rna_selected_60x60.jpg) | Mixed |
BAI1 | Brain-specific angiogenesis inhibitor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
BAI3 | Brain-specific angiogenesis inhibitor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
BDKRB1 | Bradykinin receptor B1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/2935/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2935/8078_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
BDKRB2 | Bradykinin receptor B2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/50841/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50841/116296_B_9_2_rna_selected_60x60.jpg) | Mixed |
BRS3 | Bombesin-like receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/3626/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3626/10880_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
C3AR1 | Complement component 3a receptor 1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/9405/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9405/31527_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/2720/ihc_selected_60x60.jpg) | | ![](/images/14520/ihc_cell_selected_60x60.jpg) | ![](/images/2720/6690_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/16629/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16629/37314_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CALCRL | Calcitonin receptor-like | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/8070/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8070/21294_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/39686/158078_A_4_8_selected_60x60.jpg) | ![](/images/50335/143981_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/5619/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5619/15463_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/41976/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41976/93138_B_4_2_rna_selected_60x60.jpg) | Group enriched |
CCR1 | Chemokine (C-C motif) receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/11684/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11684/32884_B_8_1_rna_selected_60x60.jpg) | Mixed |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/3793/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3793/10519_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CCR3 | Chemokine (C-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/3795/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3795/10575_B_9_3_rna_selected_60x60.jpg) | Mixed |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/31613/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31613/68831_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CCR5 | Chemokine (C-C motif) receptor 5 (gene/pseudogene) | CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14488/33886_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CCR8 | Chemokine (C-C motif) receptor 8 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/6839/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6839/16257_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CCRL2 | Chemokine (C-C motif) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/43238/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43238/93568_B_9_3_rna_selected_60x60.jpg) | Mixed |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images/13707/if_selected_60x60.jpg) | | ![](/images/13707/30523_B_8_6_rna_selected_60x60.jpg) | Expressed in all |